The role of contactin-associated protein-like 2 in neurodevelopmental disease and human cerebral cortex evolution
The contactin-associated protein-like 2 gene is associated with multiple neurodevelopmental disorders, including autism spectrum disorder (ASD), intellectual disability (ID), and specific language impairment (SLI). Experimental work has shown that is important for neuronal development and synapse fo...
Saved in:
Published in | Frontiers in molecular neuroscience Vol. 15; p. 1017144 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Research Foundation
20.10.2022
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The contactin-associated protein-like 2
gene is associated with multiple neurodevelopmental disorders, including autism spectrum disorder (ASD), intellectual disability (ID), and specific language impairment (SLI). Experimental work has shown that
is important for neuronal development and synapse formation. There is also accumulating evidence for the differential use of
in the human cerebral cortex compared with other primates. Here, we review the current literature on
, including what is known about its expression, disease associations, and molecular/cellular functions. We also review the evidence for its role in human brain evolution, such as the presence of eight human accelerated regions (HARs) within the introns of the gene. While progress has been made in understanding the function(s) of
, more work is needed to clarify the precise mechanisms through which
acts. Such information will be crucial for developing effective treatments for
patients. It may also shed light on the longstanding question of what makes us human. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Reviewed by: J. Peter H. Burbach, University Medical Center Utrecht, Netherlands; Davide Comoletti, Victoria University of Wellington, New Zealand This article was submitted to Brain Disease Mechanisms, a section of the journal Frontiers in Molecular Neuroscience Edited by: Michel J. Simonneau, École Normale Supérieure Paris-Saclay, France |
ISSN: | 1662-5099 1662-5099 |
DOI: | 10.3389/fnmol.2022.1017144 |